β-elemene: Mechanistic studies on cancer cell interaction and its chemosensitization effect

Frontiers in Pharmacology

Volumn 8, Issue MAR, 2017, Pages

  Jiang, Ziyu ^a,b   Jacob, Joe A ^a   Loganathachetti, Dinesh S ^c   Nainangu, Prasannabalaji ^c   Chen, Baoan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Anticancer; Apoptosis; Cytotoxic; Mechanism; elemene

Indexed keywords

3 METHYLADENINE; BETA ELEMENE; CASPASE 10; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CHLOROQUINE; CISPLATIN; COLCHICINE; ETOPOFOS; FAS ANTIGEN; FAS LIGAND; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; RAPAMYCIN; RECOMBINANT ENDOSTATIN; VASCULOTROPIN; VINBLASTINE; X LINKED INHIBITOR OF APOPTOSIS;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CELL CYCLE G0 PHASE; CHEMOSENSITIZATION; CYTOTOXICITY; DOWN REGULATION; DRUG POTENTIATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; UPREGULATION;

EID: 85016164614     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00105     Document Type: Short Survey

References (53)

1. Cai, D. Y., Gao, X., Wu, X. H., and Hong, T. T. (2013). Synergistic effect of beta-elemene injection combined paclitaxel injection on human breast cancer MB-468 cells: an in vitro study. Zhongguo Zhong Xi Yi Jie He Za Zhi 33, 978-982.
2. Chen, H., Shi, L., Cheng, Z. Y., Yao, L., Yang, Y. Y., and Pan, L. (2010). Effects of beta-elemene on proliferation and apoptosis of human multiple myeloma cell RPMI-8226. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18, 368-371.
3. Chen, W., Lu, Y., Wu, J., Gao, M., Wang, A., and Xu, B. (2011). Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother. Pharmacol. 67, 799-808. doi: 10.1007/s00280-010-1378-x
4. Chen, X., Wang, Y., Luo, H., Luo, Z., Zhang, T., Yang, N., et al. (2012). beta-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1. Mol. Med. Rep. 6, 989-995. doi: 10.3892/mmr.2012.1018
5. Dai, Z.-J., Tang, W., Lu, W.-F., Gao, J., Kang, H.-F., Ma, X.-B., et al. (2013). Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells. Cancer Cell Int. 13:27. doi: 10.1186/1475-2867-13-27
6. Dormond, O., Madsen, J. C., and Briscoe, D. M. (2007). The effects of mtor-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J. Biol. Chem. 282, 23679-23686. doi: 10.1074/jbc.M700563200
7. Frankfurt, O. S., and Krishan, A. (2003). Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs 14, 555-561. doi: 10.1097/00001813-200308000-00008
8. Fu, T. H., Li, J. Y., Jing, Y. Y., Sun, P. J., and Bai, X. (2013). [Effect of elemene on reversing chemoresistance to adriamycin in human stomach cancer cell line]. Zhong Yao Cai 36, 601-603.
9. Guan, C., Liu, W., Yue, Y., Jin, H., Wang, X., and Wang, X.-J. (2014). Inhibitory effect of β-elemene on human breast cancer cells. Int. J. Clin. Exp. Pathol. 7, 3948-3956.
10. Guo, H.-Q., Zhang, G.-N., Wang, Y.-J., Zhang, Y.-K., Sodani, K., Talele, T. T., et al. (2014). β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. Oncol. Rep. 31, 858-866. doi: 10.3892/or.2013.2870
11. Hu, Z., Wu, H., Li, Y., Hou, Q., Wang, Y., Li, S., et al. (2015). β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of htert expression. Anticancer Drugs 26, 531-539. doi: 10.1097/CAD.0000000000000216
12. Jiang, S., Ling, C., Li, W., Jiang, H., Zhi, Q., and Jiang, M. (2016). Molecular mechanisms of anti-cancer activities of β-elemene: targeting hallmarks of cancer. Anti Cancer Agents Med. Chem. 16, 1426-1434. doi: 10.2174/1871520616666160211123424
13. Jiang, Z.-Y., Qin, S.-K., Yin, X.-J., Chen, Y.-L., and Zhu, L. (2012). Synergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse model. Exp. Ther. Med. 4, 277-284.
14. Koul, H. K., Pal, M., and Koul, S. (2013). Role of p38 map kinase signal transduction in solid tumors. Genes Cancer 4, 342-359. doi: 10.1177/1947601913507951
15. Lee, R. X., Li, Q. Q., and Reed, E. (2012). β-Elemene effectively suppresses the growth and survival of both platinum-sensitive and-resistant ovarian tumor cells. Anticancer Res. 32, 3103-3114.
16. Li, C. L., Chang, L., Guo, L., Zhao, D., Liu, H. B., Wang, Q. S., et al. (2014). beta-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2. Asian Pac. J. Cancer Prev. 15, 10407-10412. doi: 10.7314/APJCP.2014.15.23.10407
17. Li, Q. Q., Lee, R. X., Liang, H., Wang, G., Li, J. M., Zhong, Y., et al. (2013a). β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. Int. J. Oncol. 43, 721-728. doi: 10.3892/ijo.2013.1996
18. Li, Q. Q., Lee, R. X., Liang, H., and Zhong, Y. (2013b). Anticancer activity of beta-elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res. 33, 65-76.
19. Li, Q. Q., Lee, R. X., Liang, H., Zhong, Y., and Reed, E. (2013c). Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells. Med. Oncol. 30:424. doi: 10.1007/s12032-012-0424-4
20. Li, Q. Q., Wang, G., Huang, F., Li, J. M., Cuff, C. F., and Reed, E. (2013d). Sensitization of lung cancer cells to cisplatin by beta-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of beta-elemene and its synthetic analogs. Med. Oncol. 30:488. doi: 10.1007/s12032-013-0488-9
21. Li, Q. Q., Wang, G., Liang, H., Li, J. M., Huang, F., Agarwal, P. K., et al. (2013e). β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas. Anticancer Res. 33, 1421-1428.
22. Li, Q. Q., Wang, G., Huang, F., Banda, M., and Reed, E. (2010a). Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J. Pharm. Pharmacol. 62, 1018-1027. doi: 10.1111/j.2042-7158.2010.01135.x
23. Li, Q. Q., Wang, G., Reed, E., Huang, L., and Cuff, C. F. (2010b). Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. Basic Clin. Pharmacol. Toxicol. 107, 868-876. doi: 10.1111/j.1742-7843.2010.00592.x
24. Li, Q. Q., Wang, G., Zhang, M., Cuff, C. F., Huang, L., and Reed, E. (2009). beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol. Rep. 22, 161-170. doi: 10.3892/or_00000420
25. Li, X., Lin, Z., Zhang, B., Guo, L., Liu, S., Li, H., et al. (2016). β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci. Rep. 6:21010. doi: 10.1038/srep21010
26. Li, X., Wang, G., Zhao, J., Ding, H., Cunningham, C., Chen, F., et al. (2005). Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol. Life Sci. 62, 894-904. doi: 10.1007/s00018-005-5027-1
27. Liu, J., Zhang, Y., Qu, J., Xu, L., Hou, K., Zhang, J., et al. (2011). β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 11:183. doi: 10.1186/1471-2407-11-183
28. Saraste, A., and Pulkki, K. (2000). Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45, 528-537. doi: 10.1016/S0008-6363(99)00384-3
29. Siegel, R. L., Miller, K. D., and Jemal, A. (2016). Cancer statistics, 2016. CA Cancer J. Clin. 66, 7-30. doi: 10.3322/caac.21332
30. Son, J. K., Varadarajan, S., and Bratton, S. B. (2010). Trail-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ. 17, 1288-1301. doi: 10.1038/cdd.2010.9
31. Tao, L., Zhou, L., Zheng, L., and Yao, M. (2006). Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol. 58, 24-34. doi: 10.1007/s00280-005-0137-x
32. Wang, G., Li, X., Huang, F., Zhao, J., Ding, H., Cunningham, C., et al. (2005). Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol. Life Sci. 62, 881-893. doi: 10.1007/s00018-005-5017-3
33. Wu, X. S., Xie, T., Lin, J., Fan, H. Z., Huang-Fu, H. J., Ni, L. F., et al. (2009). An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J. Pharm. Pharmacol. 61, 1653-1656. doi: 10.1211/jpp/61.12.0010
34. Xia, M., Knezevic, D., and Vassilev, L. T. (2011). p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 30, 346-355. doi: 10.1038/onc.2010.413
35. Yao, Y. Q., Ding, X., Jia, Y. C., Huang, C. X., Wang, Y. Z., and Xu, Y. H. (2008a). Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 264, 127-134. doi: 10.1016/j.canlet.2008.01.049
36. Yao, Y. Q., Xu, Y. H., Lu, J., Zhou, H. Y., and Wang, Y. Z. (2008b). [Effect of p38 MAPK on elemene-induced cell cycle arrest in C6 glioblastoma cells]. Zhonghua Yi Xue Za Zhi 88, 56-58.
37. Yu, Z. (2010). [Mechanism study of beta-elemene derivative (ET) in NB4 cell on apoptosis induction]. Zhongguo Zhong Yao Za Zhi 35, 1324-1327.
38. Yu, Z., Wang, R., Xu, L., Xie, S., Dong, J., and Jing, Y. (2011). β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ros. PLoS ONE 6:e15843. doi: 10.1371/journal.pone.0015843
39. Zhang, F., Xu, L., Qu, X., Zhao, M., Jin, B., Kang, J., et al. (2011). Synergistic antitumor effect of beta-elemene and etoposide is mediated via induction of cell apoptosis and cell cycle arrest in non-small cell lung carcinoma cells. Mol. Med. Rep. 4, 1189-1193. doi: 10.3892/mmr.2011.537
40. Zhang, H., Xu, F., Xie, T., Jin, H., and Shi, L. (2012). beta-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein. Oncol. Rep. 28, 2083-2090. doi: 10.3892/or.2012.2022
41. Zhang, J., Zhang, H., Chen, L., Sun, D. W., Mao, C., Chen, W., et al. (2014). β-Elemene reverses chemoresistance of breast cancer via regulating MDR-related microrna expression. Cell Physiol. Biochem. 34, 2027-2037. doi: 10.1159/000366398
42. Zhang, Y., Mu, X.-D., Li, E.-Z., Luo, Y., Song, N., Qu, X.-J., et al. (2013). The role of E3 ubiquitin ligase Cbl proteins in β-elemene reversing multi-drug resistance of human gastric adenocarcinoma cells. Int. J. Mol. Sci. 14, 10075-10089. doi: 10.3390/ijms140510075
43. Zhao, J., Li, Q. Q., Zou, B., Wang, G., Li, X., Kim, J. E., et al. (2007). In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int. J. Oncol. 31, 241-252.
44. Zhao, S., Wu, J., Zheng, F., Tang, Q., Yang, L., Li, L., et al. (2015). β-elemene inhibited expression of Dna methyltransferase 1 through activation of ERK1/2 and Ampka signalling pathways in human lung cancer cells: the role of Sp1. J. Cell Mol. Med. 19, 630-641. doi: 10.1111/jcmm.12476
45. Zhao, Y. F., Wang, C. R., Wu, Y. M., Ma, S. L., Ji, Y., and Lu, Y. J. (2011). P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment. Biomed. Pharmacother. 65, 151-156. doi: 10.1016/j.biopha.2011.02.009
46. Zheng, C.-P., Tong, X.-M., Yao, H.-P., Yang, J., Xu, J., Cai, X.-P., et al. (2009). [beta-elemene enhances aclarubicin-induced apoptotic effect in Hl-60 cells and its mechanism.]. Zhonghua Xue Ye Xue Za Zhi 30, 821-824.
47. Zhong, Y., Liu, J., Huo, W. M., Duan, W. L., Wang, X., and Shang, J. (2015). beta-Elemene reduces the progression of atherosclerosis in rabbits. Chin. J. Nat. Med. 13, 415-420. doi: 10.1016/S1875-5364(15)30034-0
48. Zhou, H. Y., Shen, J. K., Hou, J. S., Qiu, Y. M., and Luo, Q. Z. (2003). [Experimental study on apoptosis induced by elemene in glioma cells]. Ai Zheng 22, 959-963.
49. Zhou, J., He, L.-L., Ding, X.-F., Yuan, Q.-Q., Zhang, J.-X., Liu, S.-C., et al. (2016). Combinatorial antitumor effect of rapamycin and β-elemene in follicular thyroid cancer cells. BioMed. Res. Int. 2016:6723807. doi: 10.1155/2016/6723807
50. Zhu, T., Xu, Y., Dong, B., Zhang, J., Wei, Z., and Yao, Y. (2011a). beta-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor beta and induces sensitization to cisplatin. Oncol. Rep. 26, 405-413. doi: 10.3892/or.2011.1276
51. Zhu, T., Zhao, Y., Zhang, J., Li, L., Zou, L., Yao, Y., et al. (2011b). β-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int. J. Oncol. 38, 419-426. doi: 10.3892/ijo.2010.855
52. Zhu, T. Z., Li, X. M., Luo, L. H., Xu, Y. H., Cao, P., Liu, Y., et al. (2014). beta-Elemene inhibits proliferation through crosstalk between glia maturation factor beta and extracellular signalregulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells. Mol. Med. Rep. 10, 1122-1128. doi: 10.3892/mmr.2014.2273
53. Zou, B., Li, Q. Q., Zhao, J., Li, J. M., Cuff, C. F., and Reed, E. (2013). beta-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells. Anticancer Res. 33, 929-940.